MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ALKS
  4. News
ALKS
Quote
Short
News
Articles
Message Board

Alkermes plc (NASDAQ : ALKS ) News

Alkermes plc (NASDAQ: ALKS) News Releases

ALKS News Releases
ALKS : NASDAQ
Business Wire
Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research
ALKS : NASDAQ
Business Wire
Alkermes to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
ALKS : NASDAQ
Investing News Network
5 Biggest Biotechnology ETFs in 2026
ALKS : NASDAQ
Business Wire
Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting
ALKS : NASDAQ
Business Wire
Alkermes Showcases Data From Psychiatry Portfolio and Sleep Research into Real World Patient Experience at Spring 2026 Scientific Conferences
ALKS : NASDAQ
SeekingAlpha
Alkermes posts late-stage trial win for Lumryz in new sleep disorder
ALKS : NASDAQ
Business Wire
Alkermes Announces Positive Topline Results From REVITALYZ? Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia
ALKS : NASDAQ
KlickAnalytics
ALKS Price Target Alert: $50.00. Issued by Needham
ALKS : NASDAQ
KlickAnalytics
Buy Recommendation Issued On ALKS By Needham
ALKS : NASDAQ
SeekingAlpha
Alkermes: A Sleep Medicine Platform Hidden Inside A Mature CNS Company
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.